Colorectal disorders:
Indications for APRISO:
Maintenance of remission of ulcerative colitis (UC) in adults.
Adult:
≥18yrs: 1.5g once daily in the AM.
Children:
<18yrs: not established.
Warnings/Precautions:
Sulfasalazine allergy. Renal dysfunction or history of renal disease; assess renal function at the beginning and periodically during treatment. Phenylketonuria. Hepatic impairment. Elderly (monitor CBCs). Pregnancy (Cat.B). Nursing mothers.
Pharmacologic Class:
Aminosalicylate.
Interactions:
Do not co-administer with antacids.
Adverse Reactions:
Headache, nausea, diarrhea, upper abdominal pain, nasopharyngitis, flu-like symptoms, sinusitis; renal impairment, mesalamine-induced acute intolerance syndrome (eg, cramping, abdominal pain, bloody diarrhea, fever, headache, rash); discontinue if occurs.
Generic Availability:
NO
How Supplied:
Caps—120
Pricing for APRISO
0.375g
capsule
(Qty: 120)
Appx. price
$508
